News About: Pharm. Industry
The top 3 domestic contrast media are cruising in the foreign markets
It is shown that the Korean contrast medium manufacturers are cruising to expand in the foreign markets.
There are 3 pharmaceutical companies with 3 contrast medialeading in the field: Dongkook Pharmaceutical with Pa...
Bukwang Pharm took over the Danish bio-venture ‘Contera’Bukwang Pharm (executive director Sang-hoon Kim) announced on the 25ththat the company acquired the 100% shares of ‘Contera Pharma’, a bio-venture specializing in CNS and locate...
|
Domestic pharmaceutical companies threw money worth of KRW 33 billion in the sky due to ‘new drug adoption’
Since it is observed that financial damages on each new drug that companies give up on registration of the insurance benefit is approximately KRW 2.2 billion, it is now required for the government to step forward on t...
Daiichi Sankyo is looking for a Korean company to develop an obesity treatmentDaiichi Sankyo, one of the top 3 pharmaceutical companies in Japan, has been looking for development partners through the open innovation platform operated by NineSigma, which i...
|
What are requirements in new business?... the pharmaceutical industry is focusing on risk minimization
It feels that new businesses in the pharmaceutical industry are focused more on stability than sales.
According to the industry concern, when entering new markets, mostpharmaceutical companies concentrate more on min...
The 2nd selection of innovative pharmaceutical companies has chosen 5 certified companiesThe 2ndselection result of innovative pharmaceutical companies has finally been announced.
The Ministry of Health and Welfare announced the 2014certification result and perform...
|
Will GSK succeed in salesman evaluation without sales performance?
GSK is getting ready to apply a new evaluation measure for individual sales bonuses.
Categories to evaluate for the sales bonus are globally same for the company: the expertise level of salesman, the quality of servi...
The top 4 companies challenged a pre-launch of the Celebrex generic product next year
The top 4 companies, Yuhan Corporation, Daewoong Pharmaceutical, Hanmi Pharmaceutical and Chong Kun Dang, has begun to prevent preoccupation of a generic drug, Celebrex (Celecoxib), the blockbuster-level anti-inflamma...
Active domestication of the Korean contrast agent market worth of KRW 200 billion…and entry of Ilsung Pharmaceuticals
As domestically developed products have entered in the contrast agent market, worth of KRW 200 billion currently led by Bayer Healthcare and GE Healthcare, the industry has paid attention in the dynamics of the market...
OTC drugs of multinational pharmaceutical companies are more expensive in Korea than in others
Research about prices of OTC (Over The Counter) drugs and non-pharmaceutical products that multinational pharmaceutical companies produces and sells showed that they are more expensive in Korea than ones in elsewhere....
